Abstract

Background and objective: Hyperglycemia on admission was associated with worse clinical outcomes after mechanical thrombectomy (MT) of acute ischemic stroke (AIS). We evaluated whether increased postoperative fasting glucose (PFG) was also related to poor clinical outcomes in patients who underwent MT treatment.Methods: Consecutive patients with large vessel occlusion underwent MT in our center were included. Admission glucose and fasting glucose levels after MT treatment were evaluated. Primary outcome was 90-day unfavorable outcomes (modified Rankin Scale score of 3–6). Secondary outcome was the rate of symptomatic intracranial hemorrhage (sICH) after MT treatment. The association of PFG and 90-day clinical outcome after MT treatment was determined using logistic regression analyses.Results: One hundred twenty seven patients were collected. The median postoperative fasting glucose level was 6.27 mmol/L (IQR 5.59–7.62). Fourteen patients (11.02%) had sICH, and fifty-eight patients (45.67%) had unfavorable outcomes at 90-day after MT. After adjustment for potential confounding factors, PFG level was an independent predictor of 90-day unfavorable outcome (OR 1.265; 95% CI 1.017–1.575; p = 0.035) and sICH (OR 1.523; 95% CI 1.056–2.195; p = 0.024) after MT. In addition, older age, higher baseline NIHSS score, and higher postoperative NLR were also associated with unfavorable outcomes at 90-day after MT treatment.Conclusions: Increased PFG is associated with unfavorable outcomes at 90-day and an increased risk of sICH in patients underwent MT treatment.

Highlights

  • Endovascular mechanical thrombectomy (MT) therapy is accepted as standard treatment for stroke patients caused by large vessel occlusions in anterior circulation [1]

  • Goyal et al showed that higher admission glucose and hyperglycemia were independent predictors of worse functional outcomes in patients treated with MT [12]

  • We explored the potential association between postoperative fasting glucose (PFG) level and 90-day clinical outcomes in patients treated with MT

Read more

Summary

Introduction

Endovascular mechanical thrombectomy (MT) therapy is accepted as standard treatment for stroke patients caused by large vessel occlusions in anterior circulation [1]. Hyperglycemia is common and independently associated with worse clinical outcomes in AIS patients [3]. Several studies found that hyperglycemia on admission or fasting hyperglycemia were associated with worse outcomes in patients treated with intravenous alteplase [9, 10]. Huo et al showed that higher admission blood glucose was independently associated with poor clinical outcome at 3 months in patients experienced MT [11]. Goyal et al showed that higher admission glucose and hyperglycemia were independent predictors of worse functional outcomes in patients treated with MT [12]. Hyperglycemia on admission was associated with worse clinical outcomes after mechanical thrombectomy (MT) of acute ischemic stroke (AIS). We evaluated whether increased postoperative fasting glucose (PFG) was related to poor clinical outcomes in patients who underwent MT treatment

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call